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Introduction
The life expectancy of women is increasing, but the average 
age of women at the time of menopause is about 50 years. 
According to the 2012 World Health Organization’s an-
nual report, global life expectancy at birth in 2012 was 68.1 
years, Japanese women was 87 years which is the first rank, 
Spanish women was 68.1 (the second rank), and the Korean 
women was 84.6 years (the eighth rank) [1]. As women gets 
older, the prevalence of complications such as osteoporosis 
and bone fractures increase, and these could be considerable 
public health problem which cause a lot of social cost [2]. 
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Objective
We evaluated the combined effects of vitamin D and daily calcium intake on bone mineral density (BMD) and 
osteoporosis in Korean postmenopausal women.
Methods
This study is a cross-sectional study consisting of 1,921 Korean postmenopausal women aged 45 to 70 years without thyroid 
dysfunction, from the 2008–2011 Korean National Health and Nutrition Examination Survey. Participants were classified 
into six groups according to serum 25-hydroxyvitamin D (25(OH)D) levels and daily calcium intake. BMD was measured 
using dual-energy X-ray absorptiometry at femur and at lumbar spine, and the serum vitamin D levels were measured by 
radioimmunoassay. 
Results
The BMD divided according to serum 25(OH)D and daily calcium intakes were not statistically different among the 
groups. However, when both daily calcium intake and serum 25(OH)D were not sufficient, risk of osteopenia and 
osteoporosis showed significant increase in both femur neck and lumbar spine (odds ratio [OR] 2.242, P=0.006; OR 
3.044, P=0.001; respectively). Although daily calcium intake was sufficient, risks of osteopenia and osteoporosis 
significantly increased in lumbar spine group if serum 25(OH)D is <20 ng/mL (OR 2.993, P=0.006).
Conclusion
The combined effects of insufficient daily calcium intake and vitamin D deficiency may cause low BMD and increase in 
prevalence of osteopenia and osteoporosis in Korean postmenopausal women aged 45 to 70 years. 
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Postmenopausal osteoporosis occurs very commonly because 
of age related bone loss [3]. In previous studies, estrogen 
depletion are resulted from an imbalance in bone modeling 
and this can lead to an accelerated phase of bone loss and an 
efflux of bone-derived calcium to the extracellular fluids [4]. 
The increased fragility of bone due to changes in metabolism 
has also been investigated in experimental studies in rats and 
women [5,6]. These conditions are closely associated with 
osteoporosis and fractures that require major surgery. These 
complications can also cause women to be restricted to bed 
rest which consequently reduces their quality of life after 
menopause. 
The daily calcium intake and vitamin D are widely consid-
ered as the most important supplementations for preventing 
osteoporosis in postmenopausal women [7]. As women age, 
the efficiency of calcium absorption through the intestine is 
also decreased, and women are known to lose approximately 
200 mg of calcium per day in the first 3 to 4 years of meno-
pause [8]. Insufficient calcium intake and reduced calcium ab-
sorption can result in secondary hyperparathyroidism, which 
can augment bone resorption. Vitamin D, which is activated 
in the form of 1,25-dihydroxyvitamin D, facilitates intestinal 
calcium absorption. Not only that, but when it is deficient, it 
impairs bone mineralization, as well as muscle strength and 
balance, which may consequently increase the risk of falling 
[9]. Previous meta-analyses of randomized controlled studies 
have proved that postmenopausal women who took suffi-
cient calcium and vitamin D had a decreased risk of fracture 
[10]. However, there is still a lack of studies on the combined 
effects of calcium and vitamin D to bone mineral density (BMD) 
and osteoporosis in Korean postmenopausal women. There-
fore, it is very crucial to evaluate the risk of osteoporosis and 
advise postmenopausal women to take calcium or vitamin D 
to improve their quality of life.
Therefore, the present study aimed to assess the combined 
effects of one’s daily calcium intake and vitamin D level on 
the BMD and prevalence of osteopenia and osteoporosis in 
Korean postmenopausal women aged 45 to 70 years.
Materials and methods
1. Participants
This study was developed from the Korean National Health 
and Nutrition Examination Survey (KNHANES) IV (data from 
2008 and 2009) and KNHANES V (data from 2010 and 2011). 
These surveys were performed annually by the Korean Minis-
try of Health and Welfare with approval from the institutional 
review board of the Korea Centers for Disease Control and 
Prevention. Using rolling survey sampling, subjects participat-
ed in a complex, stratified, probability cluster survey of a rep-
resentative sample in South Korea. About 4,000 households 
were involved in 2008 and 2009, and about 3,840 house-
holds were involved in 2010 and 2011 from January through 
December of the respective year. A health interview survey, 
nutrition survey, and health examination survey (physical mea-
surements, laboratory test results, BMD level and body mass 
index [BMI]) were administered. All surveys were conducted 
by trained interviewers who did not have any information 
about the participants; surveys were completed during home 
visit, and they were filled out by the participants or through 
an interview format. Informed consent was obtained from all 
participants and the questionnaires were randomly complet-
ed. This study was approved by the institutional review board 
of Severance Hospital, Yonsei University College of Medicine.
Initially we only selected postmenopausal women aged 45 
to 70 years for this study. Women with thyroid dysfunction 
or women who underwent hysterectomy and/or bilateral 
oophorectomy, and early menopausal women whose age at 
menopause was less than 40 years were excluded. In addi-
tion, subjects who did not complete the questionnaires re-
garding smoking history, physical activity, history of hormonal 
therapy, menopausal age, and family history of fracture were 
not included. Women who did not provide blood samples for 
25-hydroxyvitamin D (25(OH)D), nutritional information about 
their daily calcium intake, and anthropometric measurements, 
including height, weight, and waist circumference were ex-
cluded. Ultimately, 1,921 participants were included in this 
study. Subjects were divided into 6 subgroups according to 
the combination of daily calcium intake (calcium <400, ≥400 
and <800, ≥800 mg/day) and serum 25(OH)D (≤20 and >20 
ng/mL) levels.
2.  Measurements of the clinical variables and blood 
analysis
We collected clinical information from standardized question-
naires regarding participants’ menopausal age, smoking his-
tory, physical activity, history of hormone replacement therapy, 
family history of fracture, and daily calcium intake. These 
surveys examined the anthropometric measurements includ-
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ing height, weight, and waist circumference, and we used the 
definition of obesity as BMI level equal to more than 25 kg/m2 
(BMI ≥25 kg/m2). We divided subjects into two groups: never 
smokers and smokers (current smokers and ex-smokers). We 
defined regular physical activity as moderate or vigorous exer-
cise for >20 minutes at least three times per week. The daily 
calcium intake amounts were obtained from the sum of the 
amounts of calcium contained in foods consumed individually 
per day. 
Blood samples were collected after overnight fasting. Serum 
25(OH)D levels were assessed by radioimmunoassay (DiaSorin, 
Stillwater, MN, USA) using a gamma-counter (1470, Wizard; 
PerkinElmer, Turku, Finland) and (25(OH)D) 125I RIA Kit (Dia-
Sorin). All blood samples were analyzed at the central testing 
institute (NeoDin Medical Institute, Seoul, Korea). We defined 
a vitamin D deficiency as a serum 25(OH)D level less than 20 
ng/mL according to the Endocrine Society’s clinical practical 
guideline [2]. 
3. BMD measurement
BMD was measured using dual-energy X-ray absorptiometry 
at total hip, femur neck and lumbar spine (L1–L4). We divided 
participants into three groups: normal, osteopenic, and osteo-
porotic, according to the T-score level from the World Health 
Organization’s criteria for BMD. We defined osteoporosis as 
BMD level -2.5 standard deviations (SDs) or lower and osteo-
penia as a BMD level between -1 SD and -2.5 SDs from the 
reference BMD level, otherwise, the BMD level was consid-
ered normal [11,12]. 
4. Statistical analysis
Continuous variables were compared by using one-way analy-
sis of variance to evaluate differences between the six groups, 
and categorical variables were analyzed using the chi-square 
test or Fisher’s exact test. Continuous and categorical vari-
ables are indicated as mean±SD and values (percentages), re-
spectively. To compare differences in the BMD levels of femur 
neck and lumbar spine between the low and high 25(OH)
D level groups for each daily calcium intake level group, an 
analysis of covariance model was fitted with adjustments for 
age and weight. The result was indicated as estimated mean 
(standard error) and visualized with a figure for better under-
standing. To compare differences in the BMD levels of the fe-
mur neck and lumbar spine between the daily calcium intake 
level groups (<400, ≥400 and ≥800, ≥800 mg/day) groups 
for each 25(OH)D level group, analysis of covariance model 
was also fitted with adjustments for age and weight and the 
results were expressed in tables and figures. A trend test was 
performed to determine whether there was a significant trend 
in the BMD levels of the femur neck and lumbar spine among 
6 subdivided groups. Logistic regression modeling was per-
formed to determine the odds ratios (ORs) of prevalence of 
osteopenia and osteoporosis in other five groups compared to 
subjects taking calcium equal to greater than 800 mg per day 
and having sufficient serum vitamin D. All data analyses were 
performed by using SAS ver. 9.3 (SAS Institute Inc., Cary, NC, 
USA).
Results
The baseline characteristics of the participants are presented 
in Table 1. Among 1921 participants, numbers of people 
included in the group 1 to 6 were 669, 421, 408, 238, 97 
and 88, respectively. The ages were 59.7±6.5, 61.3±6.2, 
58.4±6.7, 58.9±6.1, 58.1±6.4, 59.6±6.3 years old, and the 
ages at menopause were 49.9±3.9, 49.2±3.8, 49.3±3.7, 
49.2±3.5, 50.8±3.6, 50.2±3.4 years old (P<0.001, P=0.152, 
respectively). The mean BMI and the proportions of BMI, 
<18.5, ≥18.5 and <25, ≥25 kg/m2, were not statistically dif-
ferent among the 6 groups (P=0.609, P=0.197, respectively). 
Proportions of history of bone fracture, smoking history and 
estrogen therapy also did not show statistically significant dif-
ferences among the 6 groups (P=0.797, P=0.522, P=0.468, 
respectively). The BMD of femur neck and lumbar spine were 
statistically different according to the 6 groups (femur neck: 
0.610±0.100, 0.654±0.099, 0.626±0.107, 0.655±0.095, 
0.624±0.967, 0.658±0.102 g/cm2, P<0.001; lumbar spine: 
0.765±0.115, 0.822±0.117, 0.790±0.132, 0.824±0.132, 
0.798±0.126, 0.830±0.132 g/cm2, P<0.001; respectively). 
The proportions of normal to osteopenia to osteoporosis, and 
normal to osteopenia and osteoporosis in femur neck and 
lumbar spine were statistically different among the 6 groups. 
Table 2 shows comparisons of BMD in femur neck and 
lumbar spine, in between groups which were classified ac-
cording to serum 25(OH)D levels, within daily calcium intake 
classifications. Among participants taking moderate amounts 
of calcium (400≤ calcium <800 mg/day), femur neck BMD 
showed tendency of difference according to the status of 
serum 25(OH)D (P=0.088). In the groups taking calcium <400 
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and ≥800 mg/day, femur neck BMD did not reveal significant 
difference according to serum vitamin D levels (P=0.351, 
P=0.892, respectively). Similarly, for lumbar spine BMD level, 
no significant difference was noted between the groups clas-
sified according to serum 25(OH)D levels, within each daily 
calcium intake group (P=0.388, P=0.458, P=0.487, respec-
tively). These data are expressed in Fig. 1.
Contrary to Table 2, Table 3 shows comparisons of femur 
neck and lumbar spine BMD according to amounts of daily 
calcium intake within vitamin D sufficient and insufficient 
groups. There were no significant differences among the 
groups in both serum 25(OH)D <20 ng/mL and ≥20 ng/mL 
groups in femur neck BMD (P=0.508, P=0.311, respectively). 
On the other hand, in lumbar spine BMD, there was a sig-
nificant trend toward the increase in BMD within vitamin 
sufficient group (P=0.087), whereas no difference was noted 
within vitamin insufficient group (P=0.624). These data are 
shown in Fig 2.
Table 4 shows OR for osteopenia and osteoporosis of femur 
neck and lumbar spine according to daily calcium intake and 
serum vitamin D levels. The logistic regression model was 
adjusted by age, BMI, physical activity, smoking history, his-
tory of estrogen therapy and history of fracture. The reference 
group was set as the subgroup of postmenopausal women 
whose calcium intake is ≥800 mg/day and serum 25(OH)D 
level ≥20 ng/mL, and the prevalence of osteopenia and os-
teoporosis in the rest 5 groups were compared with the refer-
ence group. The ORs of subjects taking daily calcium ≥400 
and <800 mg/day with serum 25(OH)D <20 ng/mL, subjects 
taking daily calcium <400 mg/day and serum 25(OH)D <20 
ng/mL, compared to the reference group were significantly 
higher in prevalence of osteopenia and osteoporosis in femur 
neck (OR 2.167, 95% confidence interval [CI] 1.195 to 3.932, 
P=0.011; OR 2.242, 95% CI 1.256 to 4.003, P=0.006; re-
spectively). Comparing subgroups with the reference group, 
the ORs for lumbar spine in 4 groups were significantly dif-
ferent (group 1: OR 3.044, 95% CI 1.569 to 5.906, P=0.001; 
group 3: OR 2.721, 95% CI 1.382 to 5.359, P=0.004; group 
4: OR 2.213, 95% CI 1.090 to 4.492, P=0.028; group 5: OR 
2.993, 95% CI 1.372 to 6.530, P=0.006). 
Discussion
We concluded that a lower daily calcium intake and insuf-
ficient serum vitamin D level may result in a low BMD in both 
femur neck and lumbar spine, with higher prevalence of os-
teopenia and osteoporosis in postmenopausal women. Lum-
bar spine BMD seems to be more affected by both insufficient 
daily calcium intake and serum vitamin D level than femur 
neck BMD. Moreover, although daily calcium is sufficiently 
taken, the lumbar spine BMD could be affected negatively 
when serum vitamin D is insufficient. 
The effects of vitamin D and calcium are known to be con-
siderable factors for maintaining BMD levels [13,14]. Although 
there is no consensus on optimal serum levels of 25(OH)D, 
most experts consider 25(OH)D less than 20 ng/mL to be vita-
min D deficiency [15-19]. When serum 25(OH)D is deficient, 
it is known to affect bone metabolism through osteoclastic 
bone resorption and bone loss induced by increase in para-
thyroid hormone secretion as well as decrease in muscle mass 
and function [17,20]. Calcium is a mineral component which 
Fig. 1.  Differences in bone mineral density (BMD) of femur neck and lumbar spine (subgroup analysis according to daily calcium [Ca] in-
take). (A) Femur neck and (B) lumbar spine. 25(OH)D, 25-hydroxyvitamin D.
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influences the skeletal and smooth muscles, which 99% is 
stored in the bones in the form of hydroxyapatite. Deficient 
dietary consumption of calcium leads to lower bone mineral 
content and BMD, which in long-term leads to osteopenia 
and osteoporosis [21]. 
Some previous studies tried to investigate on the relation-
ship of vitamin D and calcium intake to BMD levels. One 
cross-sectional study conducted with Chinese adolescents 
concluded that the high-dose cholecalciferol therapy would 
improve calcium absorption, but the effect would not be 
significant and would not result in favorable effects on BMD 
level [22]. In one randomized controlled trial, they were to 
look for whether high dose of vitamin D would be better than 
the standard dose for increasing BMD and reducing bone 
turnover in postmenopausal women. They concluded that 
higher dosage of vitamin D than the standard dose would not 
alter or increase slightly with no significance on BMD in all 
measured sites in postmenopausal women [23]. 
Concurrently, there are relatively few studies on the relation-
ship of both calcium and vitamin D on BMD status, and the 
efficacy of maintaining adequate levels of calcium and vitamin 
D for preventing osteoporotic fractures is still controversial 
[24]. Our purpose of the study was to reveal the prevalence 
of osteopenia and osteoporosis, not fracture. But, when con-
sidering the fracture risk increases in bone being in a status of 
osteoporosis, our study showed that when both daily calcium 
intake and serum vitamin D levels are not adequate, the risks 
of osteopenia and osteoporosis increase in both femur neck 
and lumbar spine. Also, insufficient levels of calcium and vi-
tamin D seem to affect more on lumbar spine than on femur 
neck. Not consistent with our study, in one large random-
ized trial by Women’s Health Initiative involving of more than 
36,000 postmenopausal women, daily calcium intake of 1,000 
mg with daily vitamin D intake of 400 IU did not have signifi-
cant association on bone fracture, although post hoc analyses 
revealed significance within women 60 years old or older 
[25]. On the other hand, like our study, another meta-analysis 
showed both calcium and vitamin D supplementations would 
reduce fracture risk, especially in women with old age or 
those taking low amounts of calcium or vitamin D [26].
Previously, in one study reported that treatment of vitamin 
D deficiency in asymptomatic people might reduce mortality 
risk in elderly people and risk for falls but not fractures [27]. 
It emphasizes the importance of adequate level of serum vi-
tamin D, but it is concluding that sufficient intakes of vitamin Ta
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D would not decrease the fracture risk. Contrarily, our study 
showed the importance of maintaining adequate level of 
serum vitamin D by showing the increase risk of osteopenia 
and osteoporosis in lumbar spine, in a subgroup having insuf-
ficient amounts of serum 25(OH)D level with adequate daily 
calcium intake, when compared to the reference group.
Our analysis was not perfectly consistent with other previ-
ous studies. However, it is meaningful in investigating the 
combined effects on the postmenopausal femur and lumbar 
spine BMD levels and investigating on risks of osteoporosis in 
association with stratified vitamin D level and calcium intakes. 
Sufficient vitamin D level and enough daily calcium intakes 
undeniably have positive influences on BMD and bone health. 
But in the case of insufficiency in any of the 2 variables, BMD 
was negatively affected, especially on lumbar spine. Also, in 
the circumstance of lacking both calcium and vitamin D, the 
incidence of osteopenia and osteoporosis increased in 2.242 
folds in femur neck and 3.044 folds in lumbar spine. 
The strength of this study was that we used a representative 
sample of the overall South Korean population, and rigor-
ous quality control measure the research with representative 
examples of the overall South Korean population, demanding 
quality controls were applied to the procedures in KNHANES. 
Consequently, we can consider that data from this study is 
reliable. Secondly, daily calcium intake and serum vitamin 
D levels, which are the most important variables that could 
affect osteoporosis and bone fracture, were simultaneously 
investigated. 
On the other hand, one of the drawbacks of this study is 
that this investigation was retrospective cross-sectional design 
that direct relationship between the variables could not be 
obtained through this study. Further studies will be needed 
to obtain more precise values for serum vitamin D levels and 
amounts of dietary calcium intakes. Also, selection bias might 
Table 4. The odds ratio of osteopenia and osteoporosis of femur neck and lumbar spine according to daily calcium intake and serum vi-
tamin D level 
Femur neck Lumbar spine
OR (95% CI) P-value OR (95% CI) P-value
Caa) ≥800 mg & 25(OH)D ≥20 ng/mL Reference Reference
Caa) ≥800 mg & 25(OH)D <20 ng/mL 1.820 (0.888–3.729) 0.102 2.993 (1.372–6.530) 0.006
400 mg≤ Caa) <800 mg & 25(OH)D ≥20 ng/mL 1.330 (0.706–2.508) 0.377 2.213 (1.090–4.492) 0.028
400 mg≤ Caa) <800 mg & 25(OH)D <20 ng/mL 2.167 (1.195–3.932) 0.011 2.721 (1.382–5.359) 0.004
Caa) <400 mg & 25(OH)D ≥20 ng/mL 1.201 (0.657–2.194) 0.552 1.980 (1.001–3.915) 0.050
Caa) <400 mg & 25(OH)D <20 ng/mL 2.242 (1.256–4.003) 0.006 3.044 (1.569–5.906) 0.001
Adjusted values; age, body mass index, physical activity, smoking history, history of estrogen therapy, history of fracture.
OR, odds ratio; CI, confidence interval; Ca, calcium; 25(OH)D, 25-hydroxyvitamin D.
a)Daily calcium intake.
Fig. 2. Differences in bone mineral density (BMD) of femur neck and lumbar spine (subgroup analysis according to serum vitamin D levels). (A) 
Femur neck and (B) lumbar spine. Ca, calcium; 25(OH)D, 25-hydroxyvitamin D.
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have occurred considering the cultural and habitual behavior 
difference and some other factors such as geographic loca-
tion might have affected calcium intake or serum vitamin D 
levels, which could not be considered in our study [28].  
The vitamin D and daily calcium intake are significant 
variables that affect the BMD in both femur neck and lum-
bar spine in postmenopausal women. Also, although daily 
calcium intake is sufficient, the lumbar spine BMD could be 
affected negatively when serum vitamin D is not sufficient, 
increasing the risks of osteoporosis. Therefore, supplementing 
vitamin D and calcium for postmenopausal women would be 
crucial for preventing osteoporosis and fracture. 
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